Differential expression of IFN-α and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients

Jean Philippe Herbeuval, Jakob Nilsson, Adriano Boasso, Andrew W. Hardy, Michael J. Kruhlak, Stephanie A. Anderson, Matthew J. Dolan, Michel Dy, Jan Andersson, Gene M. Shearer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

159 Scopus citations

Abstract

Loss of CD4+ T cells, the hallmark of HIV pathogenesis, was suggested to be partly due to apoptosis. We recently reported that IFN-α produced by HIV-1-activated plasmacytoid dendritic cells (pDCs) contributes to CD4+ T cell apoptosis by the TNF-related apoptosis-inducing ligand (TRAIL) death receptor (DR)5 pathway. Here, we show that HIV-1-induced intracellular expression of IFN-α in pDCs is coupled to increased expression of IFN regulatory factor 7 and MyD88 by pDCs in vivo and in vitro. Expression of IFN-α was increased in lymphoid tonsillar tissue (LT) of patients with progressive (HIVprog) compared with n on p regressive (HIVNP) HIV-1 disease and to uninfected controls. LT from HIV prog exhibited higher TRAIL and DR5 mRNA levels than LT from HIV NP or controls. TRAIL mRNA levels in LT correlated with plasma viral load. We show that HIV-1 induces IFN-α and the TRAIL/DR5 apoptotic pathway in LT, suggesting a role for these cytokines in HIV-1 immunopathogenesis.

Original languageEnglish
Pages (from-to)7000-7005
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume103
Issue number18
DOIs
StatePublished - 2 May 2006
Externally publishedYes

Keywords

  • AT-2 HIV-1
  • IRF-7
  • MyD88
  • pDC

Fingerprint

Dive into the research topics of 'Differential expression of IFN-α and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients'. Together they form a unique fingerprint.

Cite this